NDC 51285-523

Antabuse

Disulfiram

Antabuse is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Teva Women's Health, Inc.. The primary component is Disulfiram.

Product ID51285-523_13b1538b-1b37-4802-a992-08eece6fd9f8
NDC51285-523
Product TypeHuman Prescription Drug
Proprietary NameAntabuse
Generic NameDisulfiram
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2000-12-01
Marketing CategoryANDA / ANDA
Application NumberANDA088482
Labeler NameTeva Women's Health, Inc.
Substance NameDISULFIRAM
Active Ingredient Strength250 mg/1
Pharm ClassesAcetyl Aldehyde Dehydrogenase Inhibitors [MoA],Aldehyde Dehydrogenase Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51285-523-02

100 TABLET in 1 BOTTLE (51285-523-02)
Marketing Start Date2000-12-01
Marketing End Date2021-11-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51285-523-02 [51285052302]

Antabuse TABLET
Marketing CategoryANDA
Application NumberANDA088482
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2000-12-01

Drug Details

Active Ingredients

IngredientStrength
DISULFIRAM250 mg/1

OpenFDA Data

SPL SET ID:f0ca0e1f-9641-48d5-9367-e5d1069e8680
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197623
  • 210716
  • 197624
  • 210628
    • UPC Code
  • 0351285524027
  • 0351285523020

    • Pharmacological Class

    • Acetyl Aldehyde Dehydrogenase Inhibitors [MoA]
    • Aldehyde Dehydrogenase Inhibitor [EPC]

    NDC Crossover Matching brand name "Antabuse" or generic name "Disulfiram"

    NDCBrand NameGeneric Name
    51285-523AntabuseDisulfiram
    51285-524AntabuseDisulfiram
    0054-0356DisulfiramDisulfiram
    0054-0357DisulfiramDisulfiram
    0093-5035DisulfiramDisulfiram
    0093-5036DisulfiramDisulfiram
    0378-4140Disulfiramdisulfiram
    0378-4141Disulfiramdisulfiram
    42794-028DisulfiramDisulfiram
    47781-607DisulfiramDisulfiram
    60429-196DisulfiramDisulfiram
    62135-431DisulfiramDisulfiram
    62135-432DisulfiramDisulfiram
    64980-171DisulfiramDisulfiram
    64980-172DisulfiramDisulfiram
    68151-2694DisulfiramDisulfiram

    Trademark Results [Antabuse]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ANTABUSE
    ANTABUSE
    90077784 not registered Live/Pending
    Actavis Holdco US, Inc.
    2020-07-28
    ANTABUSE
    ANTABUSE
    71576391 0529206 Live/Registered
    AYERST, MCKENNA & HARRISON LIMITED
    1949-03-31
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.